Citation Impact
Citing Papers
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells
2014
Visualizing enveloping layer glycans during zebrafish early embryogenesis
2010 StandoutNobel
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
2001 StandoutScience
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial
2013
Cancer statistics, 2020
2020 Standout
Cancer Statistics, 2021
2021 Standout
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
1999
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
2013 Standout
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes
2006
Enantioselective Intramolecular CH Amination Catalyzed by Engineered Cytochrome P450 Enzymes In Vitro and In Vivo
2013 StandoutNobel
A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin
1999
Cytochrome P450 and the Individuality of Species
1999
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy
2002 Standout
New potential therapeutic targets to combat epithelial tumor invasion
2006
Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-Leukemia Reaction? A Prospective Phase II Study
2006
Chiral phase analysis of warfarin enantiomers in patient plasma in relation to CYP2C9 genotype
1998
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
1998
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials
2014
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Presence of hematopoietic stem cells in the adult liver
1996
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Endogenous cardiac glycosides, a new class of steroid hormones
2002
Antibody neutralization and escape by HIV-1
2003 StandoutNature
Abolition of oxygenase function, retention of NADPH oxidase activity, and emergence of peroxidase activity upon replacement of the axial cysteine-436 ligand by histidine in cytochrome P450 2B4
2004
Chemical remodelling of cell surfaces in living animals
2004 StandoutNatureNobel
SLAM Family Receptors Distinguish Hematopoietic Stem and Progenitor Cells and Reveal Endothelial Niches for Stem Cells
2005 Standout
Graft-versus-host disease
2009 Standout
Metabolic Labeling of Sialic Acids in Living Animals with Alkynyl Sugars
2009 StandoutNobel
Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins
2003
Organocatalytic Asymmetric Hydrolysis of Epoxides
2014 StandoutNobel
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma
2006
Monoclonal antibodies as therapeutic agents for cancer
2004
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Identification and Functional Characterization of a New CYP2C9 Variant (CYP2C9*5) Expressed among African Americans
2001
A systematic approach to protein glycosylation analysis: a path through the maze
2010
Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment
1999
EMT: 2016
2016 Standout
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Idarucizumab for Dabigatran Reversal
2015 Standout
Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes*
1998
The O-glycomap of Lubricin, a Novel Mucin Responsible for Joint Lubrication, Identified by Site-specific Glycopeptide Analysis
2014
Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes
1998
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Developmental transcription factor slug is required for effective re‐epithelialization by adult keratinocytes
2004
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
The Color Loci of Mice – A Genetic Century
2003
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
The use of mass spectrometry for the proteomic analysis of glycosylation
2006
Glycomics and glycoproteomics of membrane proteins and cell‐surface receptors: Present trends and future opportunities
2016
Comprehensive Approach to Structural and Functional Glycomics Based on Chemoselective Glycoblotting and Sequential Tag Conversion
2008
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
2013
Enantioselective α-Hydroxylation of 2-Arylacetic Acid Derivatives and Buspirone Catalyzed by Engineered Cytochrome P450 BM-3
2006 StandoutNobel
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Acute Myeloid Leukemia
2015 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Synthesis of Glycopolymers for Microarray Applications via Ligation of Reducing Sugars to a Poly(acryloyl hydrazide) Scaffold
2010 StandoutNobel
Mice with mutations of Dock7 have generalized hypopigmentation and white-spotting but show normal neurological function
2009 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment
2000
Targeted metabolic labeling of yeast N-glycans with unnatural sugars
2010 StandoutNobel
Mass spectrometry-based proteomics
2003 StandoutNature
Metabolic Functionalization of Recombinant Glycoproteins
2004 StandoutNobel
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study
2005
Identification of N-Linked Glycoproteins in Human Saliva by Glycoprotein Capture and Mass Spectrometry
2006
Toward the potential cure of leukemias in the next decade
2018
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Antibody therapy for acute myeloid leukaemia
2013
How I treat refractory and early relapsed acute myeloid leukemia
2015
Immunobiology of Allogeneic Hematopoietic Stem Cell Transplantation
2006
Granulocyte Colony-Stimulating Factor Reduces the Capacity of Blood Mononuclear Cells to Induce Graft-Versus-Host Disease: Impact on Blood Progenitor Cell Transplantation
1997
Going viral: chimeric antigen receptor T‐cell therapy for hematological malignancies
2014
Identification of Mechanism-Based Inactivation in P450-Catalyzed Cyclopropanation Facilitates Engineering of Improved Enzymes
2016 StandoutNobel
Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma
2014
Imaging the glycome
2008 StandoutNobel
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia
2007
Rapid Engraftment Without Significant Graft-Versus-Host Disease After Allogeneic Transplantation of CD34+ Selected Cells From Peripheral Blood
1997
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Mechanism by which the lectin actinohivin blocks HIV infection of target cells
2009 StandoutNobel
Bone Marrow as a Potential Source of Hepatic Oval Cells
1999 StandoutScience
Multiple Myeloma
2011 Standout
Mechanism-Based Inactivation of Human Cytochromes P450s: Experimental Characterization, Reactive Intermediates, and Clinical Implications
2007
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Mass Spectrometry in Proteomics
2001
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
A Strain-Promoted [3 + 2] Azide−Alkyne Cycloaddition for Covalent Modification of Biomolecules in Living Systems
2004 StandoutNobel
Bone Marrow Is a Reservoir for CD4+CD25+ Regulatory T Cells that Traffic through CXCL12/CXCR4 Signals
2004
Applicability of a “Pick a Winner” trial design to acute myeloid leukemia
2011
Proton-Coupled Electron Transfer
2012 Standout
Chemical Glycoproteomics
2016 StandoutNobel
The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120
2002
Mass Spectrometry and Protein Analysis
2006 StandoutScience
Structural Adaptability Facilitates Histidine Heme Ligation in a Cytochrome P450
2015 StandoutNobel
Works of Ann Hunter being referenced
Structural determination of N‐linked carbohydrates by matrix‐assisted laser desorption/ionization‐mass spectrometry following enzymatic release within sodium dodecyl sulphate‐polyacrylamide electrophoresis gels: Application to species‐specific glycosylation of α1‐acid glycoprotein
1998
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation
2005
The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome
2011
Identification of highly fucosylated N‐linked oligosaccharides from the human parotid gland
1998
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
2015
Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial
2012
Allelic Variants of Human Cytochrome P450 2C9: Baculovirus-Mediated Expression, Purification, Structural Characterization, Substrate Stereoselectivity, and Prochiral Selectivity of the Wild-Type and I359L Mutant Forms
1996
Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning – evidence for a superior outcome using melphalan combined with total body irradiation
2005
Sequencing of N-Linked Oligosaccharides Directly from Protein Gels: In-Gel Deglycosylation Followed by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry and Normal-Phase High-Performance Liquid Chromatography
1997
Chromatographic and mass spectrometric methods for the identification of phosphorylation sites in phosphoproteins
1994
Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial
2010
Baculovirus-mediated expression and purification of human FMO3: catalytic, immunochemical, and structural characterization.
1997
Characterization of a Urinary Bufodienolide Na+,K+-ATPase Inhibitor in Patients After Acute Myocardial Infarction
1998
Electrospray Ionization Mass Spectrometric Analysis of Intact Cytochrome P450: Identification of Tienilic Acid Adducts to P450 2C9
1999
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders
2002
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments]
1995